Investigation of the effectiveness of algan hemostatic agent in bleeding control using an experimental partial splenectomy model in rats
MARMARA MEDICAL JOURNAL, cilt.32, sa.1, ss.27-32, 2019 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32 Sayı: 1
- Basım Tarihi: 2019
- Doi Numarası: 10.5472/marumj.518821
- Dergi Adı: MARMARA MEDICAL JOURNAL
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.27-32
- Anahtar Kelimeler: Algan hemostatic agent, Hemostasis, Rat, Bleeding control, Splenectomy, MEDICINAL-PLANT EXTRACT, ANKAFERD BLOOD STOPPER, N-ACETYL GLUCOSAMINE, FIBRIN SEALANT, POSTOPERATIVE ADHESIONS, ACHIEVING HEMOSTASIS, SPLENIC INJURY, SWINE MODEL, EFFICACY, MANAGEMENT
- Recep Tayyip Erdoğan Üniversitesi Adresli: Evet
Özet
Objective: Algan hemostatic agent (AHA) is a plant-based hemostatic agent produced in Turkey. Although, there is a great improvement in the hemostatic technologies, more effective hemostatic products are required to be produced. The aim of this study was to demonstrate the efficacy of AHA in a partial splenectomy model in rats. In addition, in this model, postoperative abdominal adhesion was evaluated.